# My-Portfolio
# ğŸ‘‹ Hi, I'm Mala Sharma

ğŸ“ Ph.D. in Bioinformatics | ğŸ’» ML & Computational Biology Enthusiast | ğŸŒ± Lifelong Learner  
ğŸ“ Based in Chicago, IL | âœ‰ï¸ bio.rsrch18@gmail.com  
ğŸ”— [GitHub](https://github.com/biorsrch18) â€¢ [Google Scholar](https://scholar.google.com/citations?user=5OOToMcAAAAJ)

---

## ğŸ§¬ About Me

I'm a computational biologist with a strong background in **genomics**, **molecular modeling**, and **AI/ML applications in biology**. I love building pipelines that transform complex biological data into actionable insights. Currently exploring projects that blend **drug discovery**, **bioinformatics**, and **deep learning**.

---

## ğŸ”§ Tech Stack & Skills

**Bioinformatics & Cheminformatics:**  
Molecular Docking, QSAR, Pharmacophore Modeling, Molecular Dynamics (GROMACS), SwissADME, AutoDock, PyMOL, Chimera

**Genomics & Data Analysis:**  
RNA-Seq, Transcriptomics, Gene Expression Profiling, Data Annotation

**Programming & Tools:**  
Python, R, SQL, Scikit-learn, Keras, TensorFlow, NLP, Matplotlib, Seaborn, Power BI, Jupyter, VS Code, Streamlit, Flask

---

## ğŸ“Œ Featured Projects

ğŸŒ [Stock Sentiment Analyzer(Natural Language Processing)](https://github.com/biorsrch18/stock-sentiment-nlp)  
ğŸ§  [Plant Seedling Classifier (Computer Vision)](https://github.com/biorsrch18/plant-seedling-cnn)  
ğŸ’¼ Personal Loan Campaign Prediction (Machine Learning)](https://github.com/biorsrch18/Machine-Learning)_
ğŸ“Š Credit Card Users Churn Prediction (Advanced Machine Learning)(https://github.com/biorsrch18/AML_Case-Studies)
ğŸ’³ [Bank Churn Prediction (Artificial Neural Network)](https://github.com/biorsrch18/bank-churn-ann)  
ğŸŒ± [FoodHub Customer Segmentation (Python Basics)](https://github.com/biorsrch18/foodhub-segmentation)

*(More repositories coming soon!)*

---

## ğŸ“š Publications

Explore my research on [Google Scholar](https://scholar.google.com/citations?user=5OOToMcAAAAJ)

---

## â˜• Let's Connect

- ğŸ’Œ Email: bio.rsrch18@gmail.com, me4bioinfo@gmail.com
- ğŸ’¼ Open to collaborations in bioinformatics, drug discovery, and AI/ML for healthcare
